LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 89 filers reported holding LEGEND BIOTECH CORP in Q2 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,967,788 | -8.2% | 461,036 | -5.7% | 0.59% | -3.3% |
Q2 2023 | $33,738,896 | +38.7% | 488,757 | -3.1% | 0.61% | +25.4% |
Q1 2023 | $24,327,954 | -13.1% | 504,520 | -10.0% | 0.49% | -19.0% |
Q4 2022 | $27,998,980 | -44.9% | 560,877 | -54.9% | 0.60% | -46.7% |
Q3 2022 | $50,770,000 | -25.3% | 1,244,362 | +0.6% | 1.13% | +20.3% |
Q2 2022 | $68,006,000 | +6.1% | 1,236,471 | -29.9% | 0.94% | +31.3% |
Q1 2022 | $64,071,000 | -29.3% | 1,763,090 | -9.3% | 0.72% | -14.7% |
Q4 2021 | $90,597,000 | -6.7% | 1,943,717 | +1.2% | 0.84% | -10.0% |
Q3 2021 | $97,068,000 | +21.1% | 1,919,866 | -1.6% | 0.94% | +30.9% |
Q2 2021 | $80,123,000 | +44.0% | 1,951,845 | +1.8% | 0.72% | +38.3% |
Q1 2021 | $55,627,000 | +3.1% | 1,916,845 | 0.0% | 0.52% | +3.4% |
Q4 2020 | $53,978,000 | -13.4% | 1,916,845 | -5.1% | 0.50% | -27.1% |
Q3 2020 | $62,325,000 | -27.5% | 2,018,956 | 0.0% | 0.69% | -34.5% |
Q2 2020 | $85,927,000 | – | 2,018,956 | – | 1.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |